Product information

From Health Canada

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

2019-09-12

Original market date: See footnote 1

2011-12-23

Product name:

VETERGESIC MULTIDOSE

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

DIN:

02342510

Product Monograph/Veterinary Labelling:

Date: 2018-07-24 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company:

CEVA ANIMAL HEALTH INC
150 Research Park, Suite 225
Guelph
Ontario
Canada N1G 4T2

Class:

Veterinary

Species:

Cats

Dosage form(s):

Solution

Route(s) of administration:

Intramuscular

Number of active ingredient(s):

1

Schedule(s):

Narcotic (CDSA I)

 

American Hospital Formulary Service (AHFS): See footnote 3

Anatomical Therapeutic Chemical (ATC): See footnote 4

Not Applicable

Active ingredient group (AIG) number:See footnote5

0142241005

List of active ingredient(s)
Active ingredient(s) See footnote8 Strength
BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) 0.3 MG / ML
Version 4.0.3

"Page details"

Date modified: